Solid IO's CEO and CSO have been selected to join the Tech Nordic Advocates International Accelerator Programme, a highly competitive six-month growth programme for women-led tech companies building for global impact.
The Tech Nordic Advocates International Accelerator Programme brings together the most promising tech founders in the Nordics and is backed by a global network of innovation leaders across the Nordics, the US, Canada and beyond. It equips founders with the strategic support and international networks they need to scale successfully.
Participation directly supports Solid IO’s strategy to bring human-based precision diagnostics into global clinical use – aiming to remove guesswork from immunotherapies and cancer care.
“We’ve been international since day one. Joining Tech Nordic Advocates is a natural fit for our journey and helps us connect with the right people to keep the pace. It’s great to see a programme like this in Europe. We truly hope that in a few years, this won’t be such a rare opportunity. We’re looking forward to the boot camp in September, expecting open and trusted connections, fresh perspectives and positive energy that keeps us moving forward.” say Solid IO co-founders Noora Hujala and Heidi Haikala.
“We’re delighted to welcome Solid IO to Tech Nordic Advocates – a company with strong scientific foundations and bold international ambitions. This is exactly the kind of founder-led innovation we aim to champion across the Nordic and Baltic region,” says Jeanette Carlsson, CEO & Founder, Tech Nordic Advocates.
Tech Nordic Advocates is the only pan-Nordic and Baltic tech community with a truly global reach. As part of the Global Tech Advocates network, it connects 30,000 tech leaders across 48 hubs worldwide to support international growth. Solid IO’s participation in the programme aligns with its strategic focus on building international co-development partnerships and scaling human-based diagnostics globally.
https://www.technordicadvocates.org/nordics-as-female-tech-founder-frontrunner/
Join us in transforming cancer care with groundbreaking organ-on-chip technology. We’re calling on researchers, clinicians, and investors to partner with us in advancing precision medicine, accelerating innovation, and expanding global access to personalized oncology. Together, we can bring clarity and better outcomes to cancer care worldwide.